Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer

Author： Guarneri Valentina   Dieci Maria Vittoria   Conte PierFranco  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.3, 2012-02, pp. : 395-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Albumin-Bound Paclitaxel: In Metastatic Breast Cancer

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 941-948

Adis International

Access to resources Recommend Favorite

Albumin-bound paclitaxel: a next-generation taxane

By Gradishar William J  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1041-1053

Informa Healthcare

Access to resources Recommend Favorite

Albumin-Bound Paclitaxel In Metastatic Breast Cancer: A Viewpoint by Neville Davidson

By Davidson Neville  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 949-950

Adis International

Access to resources Recommend Favorite

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications

By Kudlowitz David   Muggia Franco  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 681-685

Informa Healthcare

Access to resources Recommend Favorite

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors

By Abu-Khalaf Maysa M.   Baumgart Megan A.   Gettinger Scott N.   Doddamane Indukala   Tuck David P.   Hou Shihe   Chen Nianhang   Sullivan Catherine   Lezon-Geyda Kimberly   Zelterman Daniel   Hatzis Christos   Deshpande Hari   Digiovanna Michael P.   Azodi Masoud   Schwartz Peter E.   Harris Lyndsay N.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1817-1826

Blackwell Publishing

Access to resources Recommend Favorite